Sat 3/28/2020 20:01 ET
DJIA21636.78878.454.06%TELCO159.703.312.07%GOLD1630.6020.551.26%Shanghai2772.207.210.26%
S&P 5002541.4785.653.37%BANKS314.0414.454.60%OIL21.840.763.48%BITCOIN6160.91258.144.19%
NASDAQ7502.38284.343.79%PHARM520.9210.472.01%US/EU1.110.000.01%Futures2519.1288.923.53%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Tyme Technologies - TYME)    Stock Due Diligence for All

Return Top | Return List | Reply Thread | Search | Add TYME | Ignore TYME
From: klak32 (Rep: 24)Date: 2019-07-05 09:12:18
Forum: Wall Street Pit - Thread #674089549 - List TYME msgsMsg #2792728 - Part 1/2 (Rec: 0)
The biotechnology company developing cancer metabolism based therapies said Friday its Phase II TYME-88-Panc study evaluating SM-88 in patients with advanced pancreatic cancer continues to demonstrate encouraging results and a well-tolerated safety profile.

SM-88 demonstrated median overall survival of 6.4 months as of April 25, the company said. Efficacy indicators showed strong correlation with greater overall survival. These indicators included achieving stable disease or better and decreases in circulating tumor cells, Tyme said.
Message: Endorse | Reply | Privately | Bookmark | Report Abuse User klak32: Reward | Watch | Ignore

From: klak32 (Rep: 24) reply to klak32Date: 2019-07-05 09:54:44
Forum: Wall Street Pit - Thread #674089549 - List TYME msgsMsg #2792734 - Part 2/2 (Rec: 0)
Booming now...Re: The biotechnology company developing cancer metabolism based therapies said F...

Reply to klak32 - Msg #2792728 - 07/05/2019 09:12
Message: Endorse | Reply | Privately | Bookmark | Report Abuse User klak32: Reward | Watch | Ignore


TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.